US · NIVF
NewGenIvf Group Limited
- Sector
- Healthcare · Medical - Healthcare Plans
- Headquarters
- Bangkok 10110
- Website
- newgenivf.com
Price · as of 2024-12-31
$1.71
Market cap 20.24K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $2,625.91 | +153,461.99% |
| Intrinsic Value(DCF) | $372.00 | +21,654.39% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $7,372.50 | ||||
| 2022 | $7,785.00 | $39,677.48 | $21,667.64 | $1,391.53 | $457.35 |
| 2023 | $9,255.00 | $5,908.28 | $28.65 | $86.44 | $0.00 |
| 2024 | $930.00 | $2,625.91 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates NewGenIvf Group Limited's (NIVF) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $2,625.91
- Current price
- $1.71
- AI upside
- +153,461.99%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$372.00
+21,654.39% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NIVF | NewGenIvf Group Limited | $1.71 | 20.24K | +153,462% | +21,654% | — | — | -223.33 | -100.97 | 19.49 | 4469.74 | — | -100.97 | 33.63% | -21.35% | -9.66% | -35.29% | -20.66% | -11.76% | -2.89 | -1.49 | 1.17 | 1.04 | 106.02 | -27938.00% | 578.00% | 35301.00% | -7.86% | -3.04 | -300.37% | 0.00% | 0.00% | 0.00% | -93.49 | -13.04 | 19.96 | 12.77 |
| CCM | Concord Medical Services … | $3.64 | 530.04K | +8,914% | -53% | — | +156,680% | -0.01 | 0.00 | 0.01 | -10.37 | -0.19 | 0.00 | -20.62% | -138.60% | -80.28% | 29.62% | -42.92% | -10.20% | -1.72 | -2.75 | 0.46 | 0.19 | -10.75 | 355.00% | -2855.00% | 10618.00% | -18065.77% | -0.19 | -66.96% | 0.00% | 0.00% | 0.00% | -6.74 | -4.43 | 9.34 | -1.32 |
| CDT | CDT Equity Inc. | $0.69 | 936.98K | — | +2,355% | +4,622% | — | 0.11 | 0.02 | 0.01 | 3.22 | — | -0.15 | 37.98% | 11.63% | 8.75% | 37.77% | 28.00% | 13.64% | 1.09 | -6.81 | 1.93 | 1.22 | 3.14 | -12879.00% | — | -234691.00% | 845.61% | 0.51 | 19.40% | 30.80% | 3.40% | 30.80% | 3.22 | 4.65 | 0.37 | 1.88 |
| COCH | Envoy Medical, Inc. | $0.72 | 15.07M | +3,147% | -23% | — | +2,867% | -1.16 | -1.39 | 116.08 | -2.03 | — | -1.39 | -229.78% | -8558.22% | -9242.22% | 217.79% | 381.46% | -226.68% | -1.04 | -23.60 | 1.24 | 0.84 | -0.72 | -4134.00% | -2880.00% | 977.00% | -72.47% | -2.38 | 374.98% | 9.37% | -10.90% | 9.37% | -2.09 | -2.13 | 179.09 | -39.33 |
| IVF | INVO Fertility, Inc. | $0.95 | 224.52K | +165,168% | +7,886,240% | — | — | -3.04 | 2.17 | 4.23 | -5.15 | -0.62 | -0.96 | 44.00% | -124.40% | -139.25% | -133.37% | -56.16% | -28.01% | 0.78 | -7.69 | 0.07 | 0.05 | -1.28 | 48841.00% | 11625.00% | -3926.00% | -11.43% | -0.17 | -21.88% | 0.00% | 0.00% | 0.00% | -4.53 | -11.65 | 5.63 | -2.40 |
| WORX | SCWorx Corp. | $0.33 | 1.37M | +13,567% | +79% | — | +2,775% | -1.19 | 0.30 | 0.45 | 5.66 | — | -1.00 | 24.95% | -42.13% | -38.01% | -27.24% | -30.41% | -18.00% | 0.01 | -12.09 | 0.27 | 0.26 | -0.26 | -7979.00% | -2143.00% | 3450.00% | -80.45% | -0.59 | -26.18% | 0.00% | 0.00% | 4.34% | -1.02 | -1.19 | 0.43 | -6.83 |
About NewGenIvf Group Limited
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
- CEO
- Wing Fung Siu
- Employees
- 76
- Beta
- -0.04
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($372.00 ÷ $1.71) − 1 = +21,654.39% (DCF, example).